Company Update: CVS Caremark Corporation (NYSE:CVS) – Analyst Moves: CVS, FRX, MMM

[at Forbes] – This morning, UBS increased its price target on shares of CVS Caremark (CVS) to $77 after the joint venture with Cardinal Health (CAH) was announced. In the report, UBS reiterated . . . → Read More: Company Update: CVS Caremark Corporation (NYSE:CVS) – Analyst Moves: CVS, FRX, MMM Similar posts: Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Caremark And Cardinal Health Announce Creation Of Largest Generic Sourcing Entity In U.S. The Boeing Company (NYSE:BA) – Boeing reports 17 new orders in weekly update Company Update – CVS Caremark Corporation (NYSE:CVS) – Earnings Expected to Increase for CVS Caremark (CVS)